Depakote News
Most Popular Depakote Story
Abbott suffers from Humira slowdown
Abbott Laboratories may have increased first-quarter profits by more than 50 percent, but those numbers came with two caveats: One, about half of the the profits leap is due to a one-time, $797 Read more...
Latest Headlines
- October 19, 2011
- July 1, 2011
- February 7, 2011
- April 13, 2010
- December 4, 2009
- November 9, 2009
- April 16, 2009
- December 2, 2008
- July 30, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
